Search results
Victory Capital Management Inc. Invests $6.78 Million in Biohaven Ltd. (NYSE:BHVN)
ETF DAILY NEWS· 5 hours agoVictory Capital Management Inc. acquired a new position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The ...
IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 3 hours agoDespite a dip in revenue and an increased net loss, IRIDEX Corp (IRIX) remains committed to strategic initiatives and market leadership in ophthalmic treatments.
Helius Medical Technologies Inc (HSDT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 1 day agoDespite a net loss, Helius Medical Technologies Inc (HSDT) showcases operational improvements and strategic partnerships poised to enhance future growth.
Blair’s Winding Path | Washington Post Jobs
Washington Post· 2 days agoBlair, 55, is a Philadelphia resident who used her B.A. in Mass Media Communications from the University of Pennsylvania and M.A. in Mass Media...
Capricor Therapeutics Inc (CAPR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 1 day agoA: Yes, I said great to hear from...various options. A: Thanks, Joe. Great to hear from you always really excited. We've been building this therapy alongside you for a long ...
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business...
Clearfield Progress· 14 hours agoPositive data from a Phase 2b/3 trial of NRX-101 in Treatment Resistant Bipolar Depression (TRBD); trial demonstrated depression efficacy comparable to standard of care and significant reduction ...
Earnings call: Sanara MedTech posts 10th record quarter, CEO transition
Investing.com· 1 day agoSanara MedTech Inc. (SMTI), a company specializing in surgical and wound care products, announced...
Q1 2024 Legend Biotech Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoNet loss for the quarter ended March 31, 2024, was $59.8 million or a loss of $0.16 per share compared to a net loss of $112.1 million or a loss of $0.34 per share for the same period last year ...
Q1 2024 Personalis Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoOur biopharma business grew 55% compared to the first quarter of 2023, driven by strong demand for our core immunoassay platform to support the individualized neoantigen therapy< ...
Editas Medicine Inc (EDIT) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...
GuruFocus.com via Yahoo Finance· 6 days agoQ: What are the key factors for potential differentiated durability with 100% control in your genomic therapy for sickle cell? A: Baisong Mei highlighted the importance of ...
